James Hackett

3.2k total citations
30 papers, 1.4k citations indexed

About

James Hackett is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, James Hackett has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in James Hackett's work include Neutropenia and Cancer Infections (9 papers), Blood disorders and treatments (5 papers) and Acute Myeloid Leukemia Research (4 papers). James Hackett is often cited by papers focused on Neutropenia and Cancer Infections (9 papers), Blood disorders and treatments (5 papers) and Acute Myeloid Leukemia Research (4 papers). James Hackett collaborates with scholars based in United States, United Kingdom and Australia. James Hackett's co-authors include Frankie A. Holmes, Joffre Baker, John A. Glaspy, Bertrand C. Liang, Steven Shak, Drew Watson, Laurel A. Habel, Charles P. Quesenberry, C. Alexander and Louis Fehrenbacher and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

James Hackett

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Hackett United States 16 946 497 425 297 195 30 1.4k
Reginald P. Pugh United States 19 581 0.6× 177 0.4× 221 0.5× 217 0.7× 171 0.9× 34 1.1k
Mary Cianfrocca United States 14 869 0.9× 154 0.3× 533 1.3× 232 0.8× 62 0.3× 31 1.3k
T. Hakes United States 11 880 0.9× 152 0.3× 300 0.7× 125 0.4× 61 0.3× 18 1.4k
E.J. Shpall United States 19 564 0.6× 126 0.3× 209 0.5× 254 0.9× 612 3.1× 48 1.4k
Daniel Vorobiof South Africa 18 938 1.0× 125 0.3× 300 0.7× 153 0.5× 41 0.2× 61 1.6k
Damon Disch United States 10 544 0.6× 456 0.9× 191 0.4× 235 0.8× 45 0.2× 17 1.1k
J J Costanzi United States 20 641 0.7× 87 0.2× 272 0.6× 295 1.0× 187 1.0× 36 1.2k
Susanne Taucher Austria 23 1.1k 1.1× 256 0.5× 954 2.2× 316 1.1× 50 0.3× 45 1.7k
Encarna Adrover Spain 14 864 0.9× 113 0.2× 366 0.9× 297 1.0× 29 0.1× 40 1.1k
Per‐Ebbe Jönsson Sweden 20 927 1.0× 115 0.2× 270 0.6× 239 0.8× 63 0.3× 35 1.5k

Countries citing papers authored by James Hackett

Since Specialization
Citations

This map shows the geographic impact of James Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Hackett more than expected).

Fields of papers citing papers by James Hackett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Hackett. The network helps show where James Hackett may publish in the future.

Co-authorship network of co-authors of James Hackett

This figure shows the co-authorship network connecting the top 25 collaborators of James Hackett. A scholar is included among the top collaborators of James Hackett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Hackett. James Hackett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilbert, Timothy, James Hackett, N. Bird, et al.. (2022). Long-term morbidity after surgery for perihilar cholangiocarcinoma: A cohort study. Surgical Oncology. 45. 101875–101875. 3 indexed citations
2.
Hackett, James, et al.. (2017). Supra-therapeutic oral paracetamol overdose in adults: an update for the dental team. Dental Update. 44(5). 409–414. 1 indexed citations
5.
Cesano, Alessandra, Santosh Putta, Urte Gayko, et al.. (2010). Single-Cell Network Profiliing (SCNP) Signatures Independently Predict Response to Induction Therapy In Older Patients with Acute Myeloid Leukemia (AML). Blood. 116(21). 2695–2695. 2 indexed citations
6.
Potenza, Bruce, Niren Angle, Alexandra Schwartz, et al.. (2009). Lessons learned from the institution of the Surgical Care Improvement Project at a teaching medical center. The American Journal of Surgery. 198(6). 881–888. 21 indexed citations
7.
Wu, Lin, Donglin Guo, Hong Li, et al.. (2008). Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine. Heart Rhythm. 5(12). 1726–1734. 65 indexed citations
8.
Zhou, Ming, Mary P. Bronner, Ralph J. Tuthill, et al.. (2007). Optimized RNA extraction and RT-PCR assays provide successful molecular analysis on a wide variety of archival fixed tissues. Cancer Research. 67. 4423–4423. 4 indexed citations
9.
Chang, Jenny C., Andreas Makris, Maya Gutierrez, et al.. (2007). Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. Breast Cancer Research and Treatment. 108(2). 233–240. 107 indexed citations
10.
Clark-Langone, Kim M., Jenny Wu, Chithra Sangli, et al.. (2007). Biomarker discovery for colon cancer using a 761 gene RT-PCR assay. BMC Genomics. 8(1). 279–279. 42 indexed citations
11.
Kiefer, Michael, Kenneth Hoyt, James Hackett, Michael G. Walker, & Joffre Baker. (2006). Multiple GSTM gene family members are recurrence risk markers in breast cancer. Cancer Research. 66. 846–846. 1 indexed citations
12.
Fortner, Barry, et al.. (2005). Impact of chemotherapy-induced neutropenia on quality of life: a prospective pilot investigation. Supportive Care in Cancer. 13(7). 522–528. 26 indexed citations
13.
Siena, Salvatore, et al.. (2003). A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer.. PubMed. 10(3). 715–24. 87 indexed citations
14.
Kubista, E., John A. Glaspy, Frankie A. Holmes, et al.. (2003). Bone Pain Associated with Once-Per-Cycle Pegfilgrastim Is Similar to Daily Filgrastim in Patients with Breast Cancer. Clinical Breast Cancer. 3(6). 391–398. 45 indexed citations
15.
Meza, Luís, Michael D. Green, James Hackett, Theresa Neumann, & Frankie A. Holmes. (2003). Filgrastim‐Mediated Neutrophil Recovery in Patients with Breast Cancer Treated with Docetaxel and Doxorubicin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(11). 1424–1431. 15 indexed citations
16.
Vose, Julie, Michael Crump, H M Lazarus, et al.. (2003). Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for Lymphoma. Journal of Clinical Oncology. 21(3). 514–519. 152 indexed citations
17.
Holmes, Frankie A., Stephen E. Jones, Joyce O’Shaughnessy, et al.. (2002). Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer. Annals of Oncology. 13(6). 903–909. 241 indexed citations
18.
Geiger, Ann M., et al.. (1997). Pap Smear Outreach: A Randomized Controlled Trial in an HMO. American Journal of Preventive Medicine. 13(6). 425–426. 27 indexed citations
19.
Becker, Gary D., et al.. (1994). Collagen‐assisted healing of facial wounds after mohs surgery. The Laryngoscope. 104(10). 1267–1270. 13 indexed citations
20.
Bhandari, Anil K., et al.. (1992). Grognostic significance of programmed ventricular stimulation in patients surviving complicated acute myocardial infarction: A prospective study. American Heart Journal. 124(1). 87–96. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026